CN109715059A - 用于组表征的方法和系统 - Google Patents

用于组表征的方法和系统 Download PDF

Info

Publication number
CN109715059A
CN109715059A CN201780057144.2A CN201780057144A CN109715059A CN 109715059 A CN109715059 A CN 109715059A CN 201780057144 A CN201780057144 A CN 201780057144A CN 109715059 A CN109715059 A CN 109715059A
Authority
CN
China
Prior art keywords
group
category
user
lactobacillus
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780057144.2A
Other languages
English (en)
Chinese (zh)
Inventor
丹尼尔·阿尔莫纳西德
劳伦斯·克拉尔
弗朗西斯科·奥桑顿
胡安·巴勃罗·卡德纳斯
杰西卡·里奇曼
扎迦利·阿普特
伊丽莎白·比克
奥德丽·戈达德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prosomegen
Original Assignee
Youbi Omux Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/606,743 external-priority patent/US10803991B2/en
Application filed by Youbi Omux Co filed Critical Youbi Omux Co
Publication of CN109715059A publication Critical patent/CN109715059A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Primary Health Care (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
CN201780057144.2A 2016-09-16 2017-09-18 用于组表征的方法和系统 Pending CN109715059A (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201662395939P 2016-09-16 2016-09-16
US62/395,939 2016-09-16
US15/606,743 2017-05-26
US15/606,743 US10803991B2 (en) 2014-10-21 2017-05-26 Method and system for microbiome-derived diagnostics and therapeutics
US201762520058P 2017-06-15 2017-06-15
US62/520,058 2017-06-15
US201762525379P 2017-06-27 2017-06-27
US62/525,379 2017-06-27
PCT/US2017/052098 WO2018053443A1 (en) 2016-09-16 2017-09-18 Method and system for panel characterizations

Publications (1)

Publication Number Publication Date
CN109715059A true CN109715059A (zh) 2019-05-03

Family

ID=61619786

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780057144.2A Pending CN109715059A (zh) 2016-09-16 2017-09-18 用于组表征的方法和系统

Country Status (11)

Country Link
EP (1) EP3512421A4 (pt)
JP (1) JP7114091B2 (pt)
KR (1) KR102486181B1 (pt)
CN (1) CN109715059A (pt)
AU (1) AU2017326564A1 (pt)
BR (1) BR112019005025A8 (pt)
CA (1) CA3036994A1 (pt)
CO (1) CO2019003713A2 (pt)
SG (1) SG11201901726QA (pt)
WO (1) WO2018053443A1 (pt)
ZA (1) ZA201901371B (pt)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943636A (zh) * 2019-04-11 2019-06-28 上海宝藤生物医药科技股份有限公司 一种结直肠癌微生物标志物及其应用
CN110669818A (zh) * 2019-10-30 2020-01-10 中南大学 多发性骨髓瘤肠道微生物标志物及应用和检测制剂
WO2022160358A1 (zh) * 2021-02-01 2022-08-04 苏州大学附属儿童医院 肠道微生物作为早产儿支气管肺发育不良症标志物的应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102373889B1 (ko) * 2020-01-23 2022-03-15 주식회사 에이치이엠파마 장내 환경 개선을 위한 맞춤형 솔루션을 제공하는 방법 및 서버
KR102304402B1 (ko) * 2021-03-26 2021-09-24 주식회사 에이치이엠파마 머신러닝 모델을 이용하여 비만 여부를 판별하는 방법 및 진단 장치
CN118020106A (zh) 2021-09-29 2024-05-10 富士胶片株式会社 可测定合适特征量的选择方法、可测定合适特征量的选择程序及可测定合适特征量的选择装置
CN117838736B (zh) * 2024-01-29 2024-06-14 吉林省农业科学院(中国农业科技东北创新中心) 凝结芽孢杆菌ja845在制备预防和/或治疗抗动脉粥样硬化药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331641A1 (en) * 2009-06-29 2010-12-30 Searete Llc Of The State Of Delaware Devices for continual monitoring and introduction of gastrointestinal microbes
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
CN105407728A (zh) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 用于微生物组表征、监测和治疗的方法和系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2876167A1 (en) * 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
CA2962466C (en) * 2014-10-21 2023-01-10 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
AU2016250102A1 (en) * 2015-04-13 2017-11-09 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331641A1 (en) * 2009-06-29 2010-12-30 Searete Llc Of The State Of Delaware Devices for continual monitoring and introduction of gastrointestinal microbes
CN105407728A (zh) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 用于微生物组表征、监测和治疗的方法和系统
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943636A (zh) * 2019-04-11 2019-06-28 上海宝藤生物医药科技股份有限公司 一种结直肠癌微生物标志物及其应用
CN110669818A (zh) * 2019-10-30 2020-01-10 中南大学 多发性骨髓瘤肠道微生物标志物及应用和检测制剂
CN110669818B (zh) * 2019-10-30 2021-08-24 中南大学 多发性骨髓瘤肠道微生物标志物及应用和检测制剂
WO2022160358A1 (zh) * 2021-02-01 2022-08-04 苏州大学附属儿童医院 肠道微生物作为早产儿支气管肺发育不良症标志物的应用

Also Published As

Publication number Publication date
ZA201901371B (en) 2019-11-27
CA3036994A1 (en) 2018-03-22
BR112019005025A8 (pt) 2023-03-21
JP2019528729A (ja) 2019-10-17
JP7114091B2 (ja) 2022-08-08
AU2017326564A1 (en) 2019-03-28
BR112019005025A2 (pt) 2019-06-18
KR102486181B1 (ko) 2023-01-06
SG11201901726QA (en) 2019-03-28
EP3512421A4 (en) 2021-08-11
CO2019003713A2 (es) 2019-04-30
WO2018053443A1 (en) 2018-03-22
KR20190055127A (ko) 2019-05-22
EP3512421A1 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
CN109715059A (zh) 用于组表征的方法和系统
Sweeney et al. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss
JP2020532979A (ja) 微生物に関連する女性生殖器系関連状態の特徴解析のための方法及びシステム
CN108350510A (zh) 用于胃肠健康相关病症的源自微生物群系的诊断及治疗方法和系统
JP2020528285A (ja) 微生物に関連する虫垂関連コンディションの特性評価のための方法及びシステム
CN108350502A (zh) 用于口腔健康的源自微生物群系的诊断及治疗方法和系统
JP2020532995A (ja) 鼻マイクロバイオームに関連する鼻関連特徴解析
CN108350019A (zh) 用于细菌性阴道病的源自微生物群系的诊断及治疗方法和系统
KR20200049861A (ko) 미생물 관련 유의 지수 메트릭스
CN108348168A (zh) 用于湿疹的源自微生物群系的诊断及治疗方法和系统
US20180342322A1 (en) Method and system for characterization for appendix-related conditions associated with microorganisms
CN108348167A (zh) 用于脑-颅面健康相关病症的源自微生物群系的诊断及治疗方法和系统
CN109475305A (zh) 用于微生物药物基因组学的方法和系统
CN108472506A (zh) 用于表征艰难梭菌相关病症的方法和系统
US11373732B2 (en) Aging markers of human microbiome and microbiomic aging clock
CN109152803A (zh) 用于表征与皮肤相关的病症的方法和系统
CN108348166A (zh) 用于与抗生素使用相关的感染性疾病及其它健康状况的源自微生物群系的诊断及治疗方法和系统
CN107708716A (zh) 用于微生物组分类学特征相关的状况的微生物组来源的诊断和治疗的方法及系统
CN107835692A (zh) 用于皮肤系统状况的微生物组来源的表征、诊断和治疗的方法及系统
WO2020084536A1 (en) Aging markers of human microbiome and microbiomic aging clock
CN107710205A (zh) 用于心血管疾病状况的微生物组来源的表征、诊断和治疗的方法及系统
CN108699586A (zh) 用于表征与口相关病症的方法和系统
CN107849616A (zh) 用于功能特征相关的状况的微生物组来源的表征、诊断和治疗的方法及系统
CN107849609A (zh) 用于心理健康相关状况的微生物组来源的诊断和治疗的方法及系统
US11783914B2 (en) Method and system for panel characterizations

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200513

Address after: American Maryland

Applicant after: Prosomegen

Address before: California, USA

Applicant before: UBIOME, Inc.